Cholinergic Receptor, Nicotinic Beta 4 (CHRNB4) Peptide
175.5€ (100 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Cholinergic Receptor, Nicotinic Beta 4 (CHRNB4) Peptide
category
Proteins and Peptides
provider
Abbexa
reference
abx615501
tested applications
P-ELISA
Description
Cholinergic Receptor, Nicotinic Beta 4 (CHRNB4) Peptide is a synthetic peptide.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Proteins and Peptides |
| Immunogen Target | Cholinergic Receptor, Nicotinic Beta 4 (CHRNB4) |
| Host | Synthetic |
| Recommended Dilution | BL (predicted): 0.5 mg/ml. Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Observed MW | Sequence Fragment: Internal region: C-DYRLTWNSSRYEGVN |
| Size 1 | 100 µg |
| Form | Lyophilized Reconstitute in deionized water. |
| Tested Applications | P-ELISA |
| Buffer | Prior to lyophilization: Deionized water. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| Gene ID | 1143 |
| NCBI Accession | NP_000741.1 |
| Background | Protein CHRNB4 |
| Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Descripción
Related Products
CHRNB4 antibody
After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.
Ver Producto
Recombinant Human CHRNB4
Ver Producto
Cholinergic Receptor, Nicotinic Beta 4 (CHRNB4) Antibody
After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.
Ver Producto